Table 2 Comparison of vital signs and adverse events between two groups.

From: Comparison of different propofol target-controlled infusion concentrations in children with autism spectrum disorder undergoing magnetic resonance imaging

 

2.0 Group (n = 60)

2.5 Group (n = 60)

P-value

First-time sedation success rate

55 (91.67%)

58 (96.67%)

0.439

HR (bpm)

92.36 [87.08, 100.75]

90.7 [85.27, 98.69]

0.242

RR (bpm)

23.05 [21.06, 25.92]

22.68 [21.52, 24.05]

0.537

mSBP (mmHg)

96.11 [94.25, 102]

93.54 [87.81, 96.92]

0.001

mDBP (mmHg)

46.05 [43.27, 47.64]

44.67 [42.55, 48.2]

0.332

SpO2 (%)

95.15 ± 1.88

95.01 ± 1.62

0.655

ETCO2 (mmHg)

41 [38.9, 41.88]

41.31 [38.64, 43.26]

0.419

Tachycardia*

1 (1.67%)

3 (5%)

0.611

Bradycardia*

3 (5%)

6 (10%)

0.488

Hypotension*

0 (0%)

3 (5%)

0.361

Hypertension*

0 (0%)

1 (1.67%)

1.00

Hypoxemia*

3 (5%)

5 (8.33%)

0.714

Hypercapnia*

0 (0%)

2 (3.33%)

0.476

Respiratory Depression*

2 (3.33%)

4 (6.67%)

0.675

  1. Data are shown as mean ± SD, median [IQR] and Number (%).
  2. HR Heart Rate, RR Respiratory Rate, mSBP Mean Systolic Blood Pressure, mDBP Mean Diastolic Blood Pressure, SpO2 Peripheral Oxygen Saturation, ETCO2 End-Tidal Carbon Dioxide.
  3. Tachycardia*: HR > 120 bpm; Bradycardia*: HR < 80 bpm; Hypotension*: Mean Arterial Pressure is 20% below baseline; Hypertension*: Mean Arterial Pressure is 20% above baseline; Hypoxemia*: SpO2 < 94% during examination; Hypercapnia*: ETCO2 > 50mmHg during examination; Respiratory Depression*: RR is 20% below baseline.
Back to article page